Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award | Professor | University of Toronto | Canada

Prof. Mingyao Liu, MD, MSc, is an internationally recognized biomedical scientist and academic leader renowned for his pioneering contributions to lung injury, transplantation immunology, and regenerative medicine. He currently serves as the James & Mary Davie Chair in Lung Injury, Repair and Regeneration at the University Health Network and as Director of the Institute of Medical Science at the University of Toronto, where he leads multidisciplinary teams advancing translational research in organ preservation and immunomodulation. Prof. Mingyao Liu obtained his M.D. and M.Sc. in Pathophysiology from the Second Military Medical University in Shanghai, China, followed by an intensive postdoctoral fellowship at the SickKids Research Institute in Toronto, Canada, where he began his journey into molecular mechanisms of lung disease and transplant biology. His professional experience spans decades of leadership roles, including Senior Scientist at the Toronto General Hospital Research Institute and Full Professor in the Department of Surgery at the University of Toronto, with cross-appointments in Medicine and Physiology. Prof. Mingyao Liu’s research interests focus on understanding ischemia-reperfusion injury, immune tolerance in organ transplantation, and cellular mechanisms driving lung regeneration. His laboratory employs advanced molecular biology, gene editing, single-cell transcriptomics, and ex vivo organ perfusion systems to identify therapeutic targets that improve graft survival and repair outcomes. His scientific expertise is further reflected through numerous publications in high-impact journals such as Transplantation, Scientific Reports, NPJ Digital Medicine, and The American Journal of Transplantation. Prof. Mingyao Liu has received multiple prestigious awards, including the Queen Elizabeth II Diamond Jubilee Medal, the Premier’s Research Excellence Award, and the Mel Silverman Mentorship Award, highlighting both his research excellence and commitment to nurturing the next generation of scientists. As a dedicated member of numerous professional societies such as the American Thoracic Society, The Transplantation Society, and the International Society of Heart and Lung Transplantation, he plays a significant role in shaping global biomedical research discourse. Prof. Mingyao Liu’s career reflects a rare combination of innovative science, effective leadership, and lifelong mentorship, making him one of the foremost authorities in lung transplant biology. His continued contributions are shaping the future of regenerative medicine through translational discoveries that bridge laboratory innovation with clinical excellence, reinforcing his position as a global leader dedicated to improving outcomes for patients with severe pulmonary diseases.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  1. Liu, M. (2025). Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft. Scientific Reports. 1 citation.

  2. Liu, M. (2025). Ischemia/Reperfusion upregulates genes related to PANoptosis in human lung transplants. Transplantation. 3 citations.

  3. Liu, M. (2025). L-Alanyl-L-Glutamine alleviated ischemia-reperfusion injury and primary graft dysfunction in rat lung transplants. Transplantation. 2 citations.

  4. Liu, M. (2025). Ex vivo delivery of recombinant IL-10 to human donor lungs. JHLT Open. 0 citations.

  5. Liu, M. (2025). Protective effects of 10 °C preservation on donor lungs with lipopolysaccharide-induced acute lung injury. Conference Proceedings. 1 citation.

  6. Liu, M. (2024). Improving prognostic accuracy in lung transplantation using unique features of isolated human lung radiographs. NPJ Digital Medicine. 3 citations.

  7. Liu, M. (2024). Ischemia-reperfusion responses in human lung transplants at the single-cell resolution. American Journal of Transplantation. 5 citations.

 

Eswari Vilayur | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Eswari Vilayur | Medicine and Health Sciences | Best Researcher Award

Dr. Eswari Vilayur | Medicine and Health Sciences | Medicine and Health Sciences | University of Sydney | Australia

Dr. Eswari Vilayur is a highly accomplished nephrologist and transplant physician whose career reflects a rare blend of clinical expertise, research excellence, and academic leadership. With a distinguished background in nephrology and transplantation, she has served in leading roles within hospitals, universities, and professional organizations, shaping both medical practice and healthcare policy. Her commitment to advancing renal medicine is evident through her contributions to patient-centered care, international research collaborations, and the development of innovative health services. A dedicated clinician and educator, Dr. Eswari Vilayur has consistently demonstrated an ability to translate her extensive clinical experience into impactful research and effective teaching, making her a respected leader in her field.

Professional Profile 

Education

Dr. Eswari Vilayur pursued her foundational medical education at one of the premier medical institutions in India, where she completed her Bachelor of Medicine and Bachelor of Surgery. After successfully completing her internship, she advanced her academic journey in Australia, where she achieved membership as a Fellow of the Royal Australasian College of Physicians. To further strengthen her expertise in research, she completed a Master’s degree in Clinical Epidemiology at the University of Newcastle. Currently, she is enrolled as a doctoral candidate at the University of Sydney, focusing her research on inequities in kidney transplantation and strategies to enhance access for patients across diverse populations. Her academic progression highlights her dedication to bridging clinical practice with high-quality evidence-based research.

Experience

Dr. Eswari Vilayur holds a senior role as a Staff Specialist Nephrologist and Transplant Physician, serving patients with complex renal and transplantation needs. She is also a Senior Conjoint Lecturer at the University of Newcastle, where she imparts her knowledge and mentors the next generation of physicians. Over the years, she has taken on leadership roles in clinical trials as Principal Investigator, contributing significantly to international studies that have shaped nephrology and transplantation practices worldwide. Beyond research, she is deeply committed to medical education, having taught medical students, junior doctors, and advanced trainees in nephrology. She has been actively involved in examining and supervising candidates under the auspices of the Royal Australasian College of Physicians, which underscores her influence in shaping future specialists. Her contributions also extend to hospital leadership, where she has chaired quality review committees, coordinated nephrology services, and led initiatives in specialized clinics addressing renal and obstetric care.

Research Interest

Dr. Eswari Vilayur primary research interests lie in kidney transplantation, nephrology, and clinical epidemiology. She has a particular passion for addressing health inequities, focusing on improving access to living and deceased donor kidney transplantation. Her ongoing doctoral research is centered on bridging the disparities in transplant care, aiming to create a more equitable system for patients across varied demographic and socioeconomic backgrounds. Additionally, she has been involved in landmark international multicenter trials in nephrology, including those exploring therapies for glomerular diseases and transplant-related outcomes. She has published and presented widely in national and international forums, contributing to the growing body of knowledge in nephrology while influencing policy and clinical practice.

Award

Dr. Eswari Vilayur has been recognized for her outstanding contributions to transplantation research, including receiving the Young Investigator Award at a prestigious international transplant congress. This honor reflects her ability to conduct innovative research and present findings that are highly relevant to the global nephrology community. Beyond this recognition, her leadership and involvement in multicenter international clinical trials and health service reforms further demonstrate her standing as a leader in her specialty.

Selected Publications

  • A Systematic Study of Linear C4d Deposition in Glomerular Capillary Loops in Renal Transplant Biopsies (Published 2008, 75 Citations)

  • Resistive Indices as an Independent Marker of Progression of Renal Disease (Published 2008, 64 Citations)

  • Complete Resolution of Glomerular Microtubular Deposits in Immunotactoid Glomerulopathy with Rituximab (Published 2008, 48 Citations)

  • Loss of Circadian Rhythm of Blood Pressure in Renal Transplant Recipients (Published 2013, 52 Citations)

Conclusion

Dr. Eswari Vilayur is an exceptional candidate for recognition through this award, bringing together decades of clinical expertise, a strong academic foundation, and impactful research that addresses some of the most pressing challenges in kidney health. Her dedication to equity in transplantation, leadership in international clinical trials, and commitment to educating future nephrologists demonstrate her far-reaching influence. By combining her role as a clinician, researcher, educator, and leader, Dr. Eswari Vilayur exemplifies the qualities of a globally respected physician-scientist. Her future research promises to drive meaningful change in kidney transplantation practices and health equity, ensuring her contributions continue to resonate both within the scientific community and society at large.